theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Pediatric Hematology/Oncology

Cyclophosphamide   

Questions discussed in this category


When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
2 Answers available

Is there a concern for the potential of future congenital malformations in offspring when preservation of eggs and sperm is done AFTER cyclophosphamide treatment given that it is an alkylating agent?
1 Answer available
1631218053


Papers discussed in this category


Blood advances, 2024 Aug 13
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim.

Annals of oncology : official journal of the European Society for Medical Oncology, 2018 Sep 01
Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support.

J Rheumatol, 2006 Jul 01
Therapy with granulocyte colony-stimulating factor in systemic lupus erythematosus may be associated with severe flares.

Journal of pharmacy practice, 2021 Nov 08
Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematosus.

Related Topics in Pediatric Hematology/Oncology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.